Literature DB >> 28082530

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Robert Brownell1, Teng Moua2, Travis S Henry3, Brett M Elicker3, Darin White4, Eric Vittinghoff5, Kirk D Jones6, Anatoly Urisman6, Carlos Aravena7, Kerri A Johannson8, Jeffrey A Golden1, Talmadge E King1, Paul J Wolters1, Harold R Collard1, Brett Ley1.   

Abstract

BACKGROUND: Recent studies have suggested that non-definitive patterns on high-resolution CT (HRCT) scan provide sufficient diagnostic specificity to forgo surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis (IPF). The objective of this study was to determine test characteristics of non-definitive HRCT patterns for identifying histopathological usual interstitial pneumonia (UIP).
METHODS: Patients with biopsy-proven interstitial lung disease (ILD) and non-definitive HRCT scans were identified from two academic ILD centres. Test characteristics for HRCT patterns as predictors of UIP on surgical lung biopsy were derived and validated in independent cohorts.
RESULTS: In the derivation cohort, 64/385 (17%) had possible UIP pattern on HRCT; 321/385 (83%) had inconsistent with UIP pattern. 113/385 (29%) patients had histopathological UIP pattern in the derivation cohort. Possible UIP pattern had a specificity of 91.2% (95% CI 87.2% to 94.3%) and a positive predictive value (PPV) of 62.5% (95% CI 49.5% to 74.3%) for UIP pattern on surgical lung biopsy. The addition of age, sex and total traction bronchiectasis score improved the PPV. Inconsistent with UIP pattern demonstrated poor PPV (22.7%, 95% CI 18.3% to 27.7%). HRCT pattern specificity was nearly identical in the validation cohort (92.7%, 95% CI 82.4% to 98.0%). The substantially higher prevalence of UIP pattern in the validation cohort improved the PPV of HRCT patterns.
CONCLUSIONS: A possible UIP pattern on HRCT has high specificity for UIP on surgical lung biopsy, but PPV is highly dependent on underlying prevalence. Adding clinical and radiographic features to possible UIP pattern on HRCT may provide sufficient probability of histopathological UIP across prevalence ranges to change clinical decision-making. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Histology/Cytology; Idiopathic pulmonary fibrosis; Interstitial Fibrosis; Thoracic Surgery

Mesh:

Year:  2017        PMID: 28082530      PMCID: PMC5555580          DOI: 10.1136/thoraxjnl-2016-209671

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

Authors:  John P Hutchinson; Andrew W Fogarty; Tricia M McKeever; Richard B Hubbard
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

2.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Authors:  David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

3.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

4.  Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung.

Authors:  S J Swensen; G L Aughenbaugh; J L Myers
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

5.  Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia.

Authors:  Kunihiro Yagihashi; Jason Huckleberry; Thomas V Colby; Henry D Tazelaar; Jordan Zach; Baskaran Sundaram; Sudhakar Pipavath; Marvin I Schwarz; David A Lynch
Journal:  Eur Respir J       Date:  2016-02-25       Impact factor: 16.671

6.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study.

Authors:  G Raghu; Y N Mageto; D Lockhart; R A Schmidt; D E Wood; J D Godwin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

7.  Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality.

Authors:  Anthony J Edey; Anand A Devaraj; Robert P Barker; Andrew G Nicholson; Athol U Wells; David M Hansell
Journal:  Eur Radiol       Date:  2011-03-06       Impact factor: 5.315

8.  Prevalence and prognosis of unclassifiable interstitial lung disease.

Authors:  Christopher J Ryerson; Thomas H Urbania; Luca Richeldi; Joshua J Mooney; Joyce S Lee; Kirk D Jones; Brett M Elicker; Laura L Koth; Talmadge E King; Paul J Wolters; Harold R Collard
Journal:  Eur Respir J       Date:  2012-12-06       Impact factor: 16.671

9.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Fernando J Martinez; Lyrica X Liu; Susan Murray; Meilan K Han; Ella A Kazerooni; Barry H Gross; Jeffrey Myers; William D Travis; Thomas V Colby; Galen B Toews; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

10.  Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival.

Authors:  Hiromitsu Sumikawa; Takeshi Johkoh; Thomas V Colby; Kazuya Ichikado; Moritaka Suga; Hiroyuki Taniguchi; Yasuhiro Kondoh; Takashi Ogura; Hiroaki Arakawa; Kiminori Fujimoto; Atsuo Inoue; Naoki Mihara; Osamu Honda; Noriyuki Tomiyama; Hironobu Nakamura; Nestor L Müller
Journal:  Am J Respir Crit Care Med       Date:  2007-11-01       Impact factor: 21.405

View more
  22 in total

1.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

2.  Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia.

Authors:  Sreyankar Nandy; Rebecca A Raphaely; Ashok Muniappan; Angela Shih; Benjamin W Roop; Amita Sharma; Colleen M Keyes; Thomas V Colby; Hugh G Auchincloss; Henning A Gaissert; Michael Lanuti; Christopher R Morse; Harald C Ott; John C Wain; Cameron D Wright; Maria L Garcia-Moliner; Maxwell L Smith; Paul A VanderLaan; Sarita R Berigei; Mari Mino-Kenudson; Nora K Horick; Lloyd L Liang; Diane L Davies; Margit V Szabari; Peter Caravan; Benjamin D Medoff; Andrew M Tager; Melissa J Suter; Lida P Hariri
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 21.405

3.  Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement.

Authors:  Michael Kadoch; Aleksandar Kitich; Shehabaldin Alqalyoobi; Elyse Lafond; Elena Foster; Maya Juarez; Cesar Mendez; Thomas W Smith; Garrett Wong; Walter D Boyd; Jeffrey Southard; Justin M Oldham
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

4.  Comparison between the ATS/ERS/JRS/ALAT criteria of 2011 and 2018 for Usual Interstitial Pneumonia on HRCT: a cross-sectional study.

Authors:  Laura L Wuyts; Michael Camerlinck; Didier De Surgeloose; Liesbet Vermeiren; David Ceulemans; Johan Clukers; Hans Slabbynck
Journal:  Br J Radiol       Date:  2021-02-04       Impact factor: 3.039

5.  Mosaic attenuation in non-fibrotic areas as a predictor of non-usual interstitial pneumonia pathologic diagnosis.

Authors:  Ignacio Gayá García-Manso; Juan Arenas-Jiménez; Raquel García-Sevila; Sandra Ruiz-Alcaraz; Marina Sirera-Matilla; Elena García-Garrigós; María Ángeles Martínez-García; Luis Hernández-Blasco
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

6.  N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.

Authors:  Justin M Oldham; Leah J Witt; Ayodeji Adegunsoye; Jonathan H Chung; Cathryn Lee; Scully Hsu; Lena W Chen; Aliya Husain; Steven Montner; Rekha Vij; Mary E Strek; Imre Noth
Journal:  BMC Pulm Med       Date:  2018-02-08       Impact factor: 3.317

7.  Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy.

Authors:  Yasuhiro Kondoh; Hiroyuki Taniguchi; Kensuke Kataoka; Taiki Furukawa; Ayumi Shintani; Tomoyuki Fujisawa; Takafumi Suda; Machiko Arita; Tomohisa Baba; Kazuya Ichikado; Yoshikazu Inoue; Kazuma Kishi; Tomoo Kishaba; Osamu Nishiyama; Takashi Ogura; Keisuke Tomii; Sakae Homma
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

Review 8.  Diagnosis of Idiopathic Pulmonary Fibrosis "Pragmatic Challenges in Clinical Practice".

Authors:  Vasilios Tzilas; Argyris Tzouvelekis; Serafim Chrysikos; Spyridon Papiris; Demosthenes Bouros
Journal:  Front Med (Lausanne)       Date:  2017-09-20

9.  Usual interstitial pneumonia: typical, possible, and "inconsistent" patterns.

Authors:  Pedro Paulo Teixeira E Silva Torres; Marcelo Fouad Rabahi; Maria Auxiliadora Carmo Moreira; Gustavo de Souza Portes Meirelles; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2017 Sep-Oct       Impact factor: 2.624

10.  A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.

Authors:  Jannie M B Sand; Yoshinori Tanino; Morten A Karsdal; Takefumi Nikaido; Kenichi Misa; Yuki Sato; Ryuichi Togawa; Xintao Wang; Diana J Leeming; Mitsuru Munakata
Journal:  Respir Res       Date:  2018-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.